A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DLTs

Search Conditions:
Search Keyword : DLTs
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: DLTs
Appearance Frequency: 738 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
dose-limiting toxicities
(675 times)
Neoplasms
(503 times)
MTD (362 times)
PK (76 times)
AEs (51 times)
1992 Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.
double-lumen endobronchial tubes
(21 times)
Anesthesiology
(15 times)
FOB (3 times)
PVC (3 times)
BBs (1 time)
1989 Bronchial cuff pressures of double-lumen tubes.
double-lumen tubes
(15 times)
Anesthesiology
(14 times)
OLV (4 times)
FOB (3 times)
BBs (1 time)
1993 A quality improvement study of the placement and complications of double-lumen endobronchial tubes.
dose-limiting toxic effects
(9 times)
Neoplasms
(9 times)
MTD (3 times)
CA4P (2 times)
MBC (2 times)
2008 Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.
Dental laboratory technicians
(3 times)
Thoracic Diseases
(1 time)
HRCT (1 time)
PFTs (1 time)
RR (1 time)
1990 Respiratory ill-health in dental laboratory technicians: a comparative study of GP consultation rates.
donor lymphocyte transfusions
(2 times)
Hematology
(2 times)
GVL (2 times)
BMT (1 time)
CML (1 time)
2000 Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia.
Dose-limiting toxic toxicities
(2 times)
Neoplasms
(2 times)
CDD (2 times)
mCRC (2 times)
MTD (2 times)
2012 A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.
dose-limiting-toxicities
(2 times)
Neoplasms
(2 times)
5-FU (1 time)
IRN (1 time)
RPCI (1 time)
2008 A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
distributed ledger technologies
(1 time)
Medical Informatics
(1 time)
IoT (1 time)
MAM (1 time)
Raspberry Pi (1 time)
2019 Accelerating Health Data Sharing: A Solution Based on the Internet of Things and Distributed Ledger Technologies.
10  domino liver transplantations
(1 time)
Transplantation
(1 time)
--- 2013 Evaluation of domino liver transplantations in Germany.
11  dorsal longitudinal trunks
(1 time)
Diagnostic Imaging
(1 time)
--- 2017 Comparison of the tracheal systems of Anopheles sinensis and Aedes togoi larvae using synchrotron X-ray microscopic computed tomography (respiratory system of mosquito larvae using SR-muCT).
12  dose level toxicities
(1 time)
Neoplasms
(1 time)
CCA (1 time)
MTD (1 time)
OS (1 time)
2019 Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.
13  dosing-limiting toxicities
(1 time)
Antineoplastic Agents
(1 time)
C1D1 (1 time)
ccRCC (1 time)
HDAC (1 time)
2019 Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.
14  double-layer tablets
(1 time)
Pharmacology
(1 time)
XG (1 time)
2009 Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination.
15  double-lung transplants
(1 time)
General Surgery
(1 time)
DSA (1 time)
LAS (1 time)
UNOS (1 time)
2013 Local allocation of lung donors results in transplanting lungs in lower priority transplant recipients.
16  dynamic leaching tests
(1 time)
PSCs (1 time)
2020 Pb-Based Perovskite Solar Cells and the Underlying Pollution behind Clean Energy: Dynamic Leaching of Toxic Substances from Discarded Perovskite Solar Cells.
17  Two-dose limiting toxicities
(1 time)
Neoplasms
(1 time)
DHFR (1 time)
DRAEs (1 time)
Hsp90 (1 time)
2019 Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer.